1. US food and drug administration approval summary: nivolumab plus platinum-doublet chemotherapy for the neoadjuvant treatment of patients with resectable non-small-cell lung cancer;Akinboro;J Clin Oncol,2023
2. FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer.
3. FDA approval summary: atezolizumab as adjuvant treatment following surgical resection and platinum-based chemotherapy for stage II to IIIA NSCLC;Mathieu;Clin Cancer Res,2023
4. FDA approves neoadjuvant/adjuvant pembrolizumab for resectable non-small cell lung cancer. Accessed October 02, 2023. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neoadjuvant-adjuvant-pembrolizumab-resectable-non-small-cell-lung-cancer.
5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008